Stroke prophylaxis in atrial fibrillation.
作者信息
Jolobe Oscar M
出版信息
Eur Heart J. 2006 Oct;27(19):2370. doi: 10.1093/eurheartj/ehl241. Epub 2006 Sep 5.
PMID:16954133
Abstract
摘要
相似文献
1
Stroke prophylaxis in atrial fibrillation.
Eur Heart J. 2006 Oct;27(19):2370. doi: 10.1093/eurheartj/ehl241. Epub 2006 Sep 5.
2
Ask the doctor. Is it okay to stop taking warfarin when atrial fibrillation stops?
Harv Heart Lett. 2007 Jan;17(5):7.
3
Warfarin trumps aspirin for stroke prevention in elderly.
Harv Heart Lett. 2007 Sep;18(1):7.
4
Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
J Am Geriatr Soc. 2008 Oct;56(10):1967-8. doi: 10.1111/j.1532-5415.2008.01902.x.
5
Atrial fibrillation and stroke prevention.
N Engl J Med. 2003 Sep 11;349(11):1015-6. doi: 10.1056/NEJMp038123.
6
[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8.
7
The need for new oral anticoagulants in clinical practice.
J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954.
8
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
9
Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Thromb Haemost. 2009 Mar;101(3):415-6.
10
[Between Scylla and Charybdis].
Tidsskr Nor Laegeforen. 2009 Jun 25;129(13):1322. doi: 10.4045/tidsskr.09.0618.
Zotero 插件